From April 1, 2024 to April 9, 2024, the company has repurchased 285,400 shares, representing 0.06% for CNY 15.24 million. With this, the company has completed the repurchase of 1,781,400 shares, representing 0.38% for CNY 99.99 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.08 CNY | -1.34% | +1.90% | -37.54% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.54% | 2.52B | |
-16.58% | 8.44B | |
+54.07% | 3.96B | |
-10.68% | 2.44B | |
-10.88% | 2.22B | |
-4.20% | 1.98B | |
-18.24% | 1.58B | |
-36.41% | 1.3B | |
+2.19% | 1.05B | |
-32.43% | 902M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.